Peter Vermeulen Reports Early Warning Report in respect of Infinico Metals Corp. (TSXV: INFM)

(TSX-V:INFM), UTRECHT, Netherlands, June 12, 2025 (GLOBE NEWSWIRE) — Peter Vermeulen announces that as a result of becoming the sole executive director of the fund manager for Stichting Legal Owner Plethora Private Equity (“Plethora“), he owns or controls an aggregate of 19,065,809 common shares (“Shares“) in the capital of Infinico Metals Corp. (“Infinico“) and 3,442,098 […]

Info-Tech LIVE 2025 Day 2 Highlights: Bold Strategies for AI, IT Leadership, and Digital Disruption

The second day of Info-Tech LIVE 2025 continued to build momentum, spotlighting bold leadership insights, forward-looking AI strategies, and transformative playbooks to guide IT organizations through exponential change. Info-Tech LIVE 2025 brought another wave of powerful insights to the thousands of IT leaders gathered at the Bellagio in Las Vegas for the global research and

Peter Vermeulen Reports Early Warning Report in respect of Infinico Metals Corp. (TSXV: INFM)

Peter Vermeulen Reports Early Warning Report in respect of Infinico Metals Corp. (TSXV: INFM) GlobeNewswire June 12, 2025 UTRECHT, Netherlands, June 12, 2025 (GLOBE NEWSWIRE) — Peter Vermeulen announces that as a result of becoming the sole executive director of the fund manager for Stichting Legal Owner Plethora Private Equity (“Plethora“), he owns or controls

KNBE Investor Notice: Robbins LLP Reminds Former Investors of KnowBe4, Inc. That a Class Action Has Been Filed on Their Behalf

(NASDAQ:KNBE), SAN DIEGO, June 12, 2025 (GLOBE NEWSWIRE) — Robbins LLP informs stockholders that a class action was filed on behalf of investors (i) who held KnowBe4, Inc. (NASDAQ: KNBE) common stock as of the December 7, 2022, record date that were entitled to vote on the “take private” acquisition (“Merger”) by Vista Equity Partners

KNBE Investor Notice: Robbins LLP Reminds Former Investors of KnowBe4, Inc. That a Class Action Has Been Filed on Their Behalf

KNBE Investor Notice: Robbins LLP Reminds Former Investors of KnowBe4, Inc. That a Class Action Has Been Filed on Their Behalf GlobeNewswire June 12, 2025 SAN DIEGO, June 12, 2025 (GLOBE NEWSWIRE) — Robbins LLP informs stockholders that a class action was filed on behalf of investors (i) who held KnowBe4, Inc. (NASDAQ: KNBE) common

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics

(NasdaqGM:IOVA), Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Iovance To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Iovance between May 9, 2024 and May 8, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics GlobeNewswire June 12, 2025 Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Iovance To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Iovance between May 9,

4 Emerging Graft versus Host Disease Therapies That Could Change the Treatment Landscape | DelveInsight

Key companies, such as CSL Behring, Equillium, Biocon, and medac, are advancing their assets through late-stage graft versus host disease clinical trials, driving innovation in the graft versus host disease market and creating significant growth opportunities. Graft versus host disease (GvHD) is an immune-driven disorder caused by a complex interplay between the donor's and recipient's

RCKT Investors Have Opportunity to Lead Rocket Pharmaceuticals, Inc. Securities Fraud Lawsuit

https://mma.prnewswire.com/media/2598258/THE_ROSEN_LAW_FIRM_P_A_Logo.jpg Why:Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) between February 27, 2025 and May 26, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Fortrea

(NASDAQ:FTRE), Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Fortrea To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Fortrea between July 3, 2023 and February 28, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner

Scroll to Top